AR066245A1 - Composiciones de fibrina que contienen compuestos de estroncio - Google Patents
Composiciones de fibrina que contienen compuestos de estroncioInfo
- Publication number
- AR066245A1 AR066245A1 ARP080101685A ARP080101685A AR066245A1 AR 066245 A1 AR066245 A1 AR 066245A1 AR P080101685 A ARP080101685 A AR P080101685A AR P080101685 A ARP080101685 A AR P080101685A AR 066245 A1 AR066245 A1 AR 066245A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- fibrine
- compositions containing
- containing strontium
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003438 strontium compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 108090000190 Thrombin Proteins 0.000 abstract 2
- 229910052712 strontium Inorganic materials 0.000 abstract 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 2
- 229960004072 thrombin Drugs 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000010478 bone regeneration Effects 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 238000001879 gelation Methods 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 239000012669 liquid formulation Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/502—Plasticizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Una composicion para su uso en la cicatrizacion osea y la regeneracion osea en la forma de un gel tipo hidrogel viscoelástico o de una formulacion líquida que comprende fibrinogeno, trombina y un componente inorgánico que comprende un compuesto quecontiene estroncio (Sr) y/o posiblemente otro metal tal como un compuesto que contiene calcio. El compuesto que contiene estroncio se puede disolver en las soluciones de trombina o se puede agregar al coágulo en una forma cristalina particulada. Unavez mezclados los componentes, tiene lugar la gelificacion para formar una matriz. La composicion también puede comprender un compuesto que contiene iodo que actua como plastificador.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92571607P | 2007-04-23 | 2007-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066245A1 true AR066245A1 (es) | 2009-08-05 |
Family
ID=39745302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101685A AR066245A1 (es) | 2007-04-23 | 2008-04-22 | Composiciones de fibrina que contienen compuestos de estroncio |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080260714A1 (es) |
EP (2) | EP2823829B1 (es) |
JP (2) | JP5907656B2 (es) |
KR (1) | KR101520114B1 (es) |
CN (2) | CN101668549B (es) |
AR (1) | AR066245A1 (es) |
AU (1) | AU2008242867B2 (es) |
BR (1) | BRPI0811035B8 (es) |
CA (1) | CA2686820C (es) |
CL (1) | CL2008001171A1 (es) |
CO (1) | CO6251232A2 (es) |
ES (2) | ES2573327T3 (es) |
HK (1) | HK1205961A1 (es) |
IL (1) | IL201480A0 (es) |
MX (1) | MX2009011268A (es) |
TW (1) | TWI556842B (es) |
WO (1) | WO2008131154A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1024250C2 (nl) * | 2003-09-09 | 2005-03-10 | Fluxxion B V | Vervaardiging van een microzeef, en microzeef en inrichting met een microzeef. |
MX2010003969A (es) * | 2007-10-12 | 2010-06-30 | Kuros Biosurgery Ag | Composiciones inyectables de fibrina que comprenden sal de estroncio para el aumento de tejidos. |
JP2011516228A (ja) | 2008-04-18 | 2011-05-26 | クロス・バイオサージェリー・アクチェンゲゼルシャフト | 分配装置、分配装置を含むキット、および分配装置を動作させる方法 |
WO2010081044A1 (en) * | 2009-01-08 | 2010-07-15 | Numira Biosciences, Inc. | Methods and compositions for imaging cartilage and bone |
WO2010081037A1 (en) * | 2009-01-08 | 2010-07-15 | Numira Biosciences, Inc. | Methods and compositions for imaging atherosclerotic plaques |
CN102639159B (zh) * | 2009-08-04 | 2015-04-01 | 皮斯洛克斯有限公司 | 离子取代的磷酸钙颗粒 |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
US8614190B2 (en) | 2010-06-30 | 2013-12-24 | Industrial Technology Research Institute | Thermal responsive composition for treating bone diseases |
WO2012024634A2 (en) * | 2010-08-19 | 2012-02-23 | University Of Washington Through Its Center For Commercialization | Environmentally-responsive nanocomposites and methods of their use |
JP5304939B1 (ja) * | 2012-05-31 | 2013-10-02 | 大日本印刷株式会社 | 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法 |
AU2014388246A1 (en) * | 2014-03-27 | 2016-09-01 | Novabone Products, Llc | Kit for delivering bone grafting materials |
WO2015193836A1 (en) | 2014-06-19 | 2015-12-23 | Consiglio Nazionale Delle Ricerche (Cnr) | Injectable apatitic cement ionically multi-substituted for regenerative vertebroplasty and kyphoplasty |
US10238507B2 (en) | 2015-01-12 | 2019-03-26 | Surgentec, Llc | Bone graft delivery system and method for using same |
CA3046522A1 (en) * | 2016-12-09 | 2018-06-14 | Northwestern University | Bone-promoting thermoresponsive macromolecules |
US11116647B2 (en) | 2018-04-13 | 2021-09-14 | Surgentec, Llc | Bone graft delivery system and method for using same |
US10687828B2 (en) | 2018-04-13 | 2020-06-23 | Surgentec, Llc | Bone graft delivery system and method for using same |
CN118555974A (zh) * | 2022-01-18 | 2024-08-27 | 韩国科学技术研究院 | 填料用磷灰石以及包含该磷灰石的填料组合物 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737411A (en) * | 1986-11-25 | 1988-04-12 | University Of Dayton | Controlled pore size ceramics particularly for orthopaedic and dental applications |
US4969888A (en) * | 1989-02-09 | 1990-11-13 | Arie Scholten | Surgical protocol for fixation of osteoporotic bone using inflatable device |
IT1240938B (it) | 1990-02-08 | 1993-12-27 | S.E.I.P.I. Societa' Esportazione Importazione Prodotti Industriali | Composizione vetrosa bioattiva per impianti ossei e prodotti ottenuti con tale composizione o che la comprendono |
WO1991017777A2 (en) | 1990-05-22 | 1991-11-28 | University Of Florida | Injectable bioactive glass compositions and methods for tissue reconstruction |
JPH0662381B2 (ja) * | 1990-06-26 | 1994-08-17 | 昭和薬品化工株式会社 | 骨性硬組織形成用ペースト組成物 |
US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
FR2705235B1 (fr) * | 1993-05-13 | 1995-07-13 | Inoteb | Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os. |
US5549904A (en) * | 1993-06-03 | 1996-08-27 | Orthogene, Inc. | Biological adhesive composition and method of promoting adhesion between tissue surfaces |
US6241734B1 (en) * | 1998-08-14 | 2001-06-05 | Kyphon, Inc. | Systems and methods for placing materials into bone |
US6248110B1 (en) | 1994-01-26 | 2001-06-19 | Kyphon, Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
FI101129B (sv) | 1995-01-13 | 1998-04-30 | Vivoxid Oy | Nya bioaktiva glas och deras användning |
FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
EP0929524A1 (de) * | 1996-09-18 | 1999-07-21 | Basf Aktiengesellschaft | Pyridinderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von tierischen schädlingen und schadpilzen |
JPH10236976A (ja) * | 1997-02-26 | 1998-09-08 | Chemo Sero Therapeut Res Inst | 骨形成促進剤 |
US20010016646A1 (en) * | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
FR2772746B1 (fr) * | 1997-12-23 | 2000-01-28 | Commissariat Energie Atomique | Procede de fabrication d'une ceramique apatitique, en particulier pour usage biologique |
DE69911609T2 (de) * | 1998-07-13 | 2004-07-01 | University Of Southern California, Los Angeles | Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel |
DE19956503A1 (de) * | 1999-11-24 | 2001-06-21 | Universitaetsklinikum Freiburg | Spritzbares Knochenersatzmaterial |
NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
SE522098C2 (sv) | 2001-12-20 | 2004-01-13 | Bone Support Ab | Ett nytt benmineralsubstitut |
US7247288B2 (en) * | 2002-04-18 | 2007-07-24 | Carnegie Mellon University | Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
DE10225420A1 (de) * | 2002-06-07 | 2003-12-24 | Sanatis Gmbh | Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon |
US7273523B2 (en) * | 2002-06-07 | 2007-09-25 | Kyphon Inc. | Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof |
ATE322295T1 (de) | 2002-10-03 | 2006-04-15 | Vivoxid Oy | Bioaktive glaszusammensetzung |
PL1745791T3 (pl) * | 2003-05-07 | 2013-11-29 | Osteologix As | Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu |
US6905723B2 (en) | 2003-05-30 | 2005-06-14 | Depuy Products, Inc. | Strontium-substituted apatite coating |
KR100531922B1 (ko) * | 2003-12-23 | 2005-11-29 | 주식회사 셀론텍 | 연골치료제 조성물 및 그 사용방법 |
EP1732575B1 (en) * | 2004-02-26 | 2010-12-29 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
FR2869544B1 (fr) * | 2004-05-03 | 2006-07-21 | Centre Nat Rech Scient Cnrse | Composition pour ciment injectable, utile comme substitut osseux |
ATE443541T1 (de) * | 2004-06-25 | 2009-10-15 | Strontin Aps | Zusammensetzungen mit strontium und vitamin d und ihre verwendungen |
EP1655042A1 (en) | 2004-11-02 | 2006-05-10 | Vivoxid Oy | A medical device |
ES2902872T3 (es) * | 2005-01-06 | 2022-03-30 | Kuros Biosurgery Ag | Matrices suplementadas para la reparación de fracturas óseas |
US20060216321A1 (en) * | 2005-03-24 | 2006-09-28 | Sdgi Holdings, Inc. | Solvent based processing technologies for making tissue/polymer composites |
CN1846789A (zh) * | 2005-04-14 | 2006-10-18 | 南方医院 | 一种注射型骨修复材料及其制备与应用 |
EP2021043B1 (en) * | 2006-05-26 | 2011-01-12 | Baxter International Inc. | Injectable bone void filler |
EP2029184B1 (en) * | 2006-05-26 | 2011-02-23 | Baxter International Inc. | Injectable fibrin composition for bone augmentation |
ATE452863T1 (de) | 2006-09-20 | 2010-01-15 | Inion Oy | Bioaktive glaszusammensetzungen |
-
2008
- 2008-04-18 KR KR1020097024159A patent/KR101520114B1/ko active IP Right Grant
- 2008-04-18 CA CA2686820A patent/CA2686820C/en active Active
- 2008-04-18 BR BRPI0811035A patent/BRPI0811035B8/pt not_active IP Right Cessation
- 2008-04-18 ES ES08746189.3T patent/ES2573327T3/es active Active
- 2008-04-18 EP EP14003058.6A patent/EP2823829B1/en active Active
- 2008-04-18 US US12/105,369 patent/US20080260714A1/en not_active Abandoned
- 2008-04-18 CN CN200880013518.1A patent/CN101668549B/zh not_active Expired - Fee Related
- 2008-04-18 AU AU2008242867A patent/AU2008242867B2/en not_active Ceased
- 2008-04-18 ES ES14003058.6T patent/ES2594081T3/es active Active
- 2008-04-18 MX MX2009011268A patent/MX2009011268A/es active IP Right Grant
- 2008-04-18 EP EP08746189.3A patent/EP2142224B1/en active Active
- 2008-04-18 CN CN201410019473.6A patent/CN103785058B/zh not_active Expired - Fee Related
- 2008-04-18 WO PCT/US2008/060720 patent/WO2008131154A2/en active Application Filing
- 2008-04-18 JP JP2010506402A patent/JP5907656B2/ja not_active Expired - Fee Related
- 2008-04-22 AR ARP080101685A patent/AR066245A1/es unknown
- 2008-04-23 TW TW097114976A patent/TWI556842B/zh not_active IP Right Cessation
- 2008-04-23 CL CL2008001171A patent/CL2008001171A1/es unknown
-
2009
- 2009-10-13 IL IL201480A patent/IL201480A0/en unknown
- 2009-10-23 CO CO09119370A patent/CO6251232A2/es not_active Application Discontinuation
-
2013
- 2013-06-21 JP JP2013130650A patent/JP6012551B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-14 HK HK15106694.9A patent/HK1205961A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2686820C (en) | 2016-06-28 |
CO6251232A2 (es) | 2011-02-21 |
KR20100017158A (ko) | 2010-02-16 |
TWI556842B (zh) | 2016-11-11 |
HK1205961A1 (zh) | 2015-12-31 |
JP2013216678A (ja) | 2013-10-24 |
WO2008131154A2 (en) | 2008-10-30 |
EP2142224A2 (en) | 2010-01-13 |
MX2009011268A (es) | 2009-11-02 |
WO2008131154A3 (en) | 2008-12-24 |
CL2008001171A1 (es) | 2008-11-03 |
BRPI0811035B8 (pt) | 2021-05-25 |
BRPI0811035B1 (pt) | 2018-07-31 |
IL201480A0 (en) | 2010-05-31 |
US20080260714A1 (en) | 2008-10-23 |
EP2823829A1 (en) | 2015-01-14 |
CN103785058A (zh) | 2014-05-14 |
EP2823829B1 (en) | 2016-07-20 |
BRPI0811035A2 (pt) | 2014-10-21 |
JP6012551B2 (ja) | 2016-10-25 |
TW200902096A (en) | 2009-01-16 |
AU2008242867B2 (en) | 2014-01-23 |
CN103785058B (zh) | 2016-12-07 |
CN101668549B (zh) | 2014-04-09 |
ES2594081T3 (es) | 2016-12-15 |
ES2573327T3 (es) | 2016-06-07 |
CA2686820A1 (en) | 2008-10-30 |
CN101668549A (zh) | 2010-03-10 |
AU2008242867A1 (en) | 2008-10-30 |
KR101520114B1 (ko) | 2015-05-13 |
EP2142224B1 (en) | 2016-03-23 |
JP2010525070A (ja) | 2010-07-22 |
JP5907656B2 (ja) | 2016-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066245A1 (es) | Composiciones de fibrina que contienen compuestos de estroncio | |
CO2018012181A2 (es) | Compuestos arilo o heteroarilo sustituidos con amino como inhibidores de ehmt1 y ehmt2 | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
PE20090605A1 (es) | Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma | |
CO6290631A2 (es) | Composición oral que contiene amino ácidos y un agente blanqueador | |
EA201000089A1 (ru) | Применение гомо- и сополимеров для стабилизации составов активных ингредиентов | |
AR053292A1 (es) | Un sistema de suministro para dos o mas componentes acivos como parte de una composicion comestible | |
BRPI0511478A (pt) | composições de vidro como aditivo antimicrobiano para materiais dentários | |
CR9620A (es) | Composicion agricola | |
PA8509801A1 (es) | Compuestos antibioticos de azalida | |
CR20120649A (es) | Compuestos, composiciones de tioacetato y métodos de uso | |
CO6400200A2 (es) | Preparaciones basadas en fibrinógeno y polisacáridos sulfatados | |
BRPI0916286B8 (pt) | amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica | |
AR062212A1 (es) | Composicion y metodo en relacion con la prevencion y la solucion del dano del gel surfactante | |
EA200800514A1 (ru) | Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения | |
GT200600520A (es) | Agentes antibacterianos | |
HRP20191347T1 (hr) | Kirurško ljepilo u kojem su kolagen i fibrin pomiješani i metoda za pripremu istog | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
ATE403469T1 (de) | Emboliezusammensetzungen enthaltend pyrogenes silicium | |
AR061054A1 (es) | Compuestos acidos de glicerilo y glicol | |
EA200700130A1 (ru) | Композиции, содержащие стронций и витамин d, и их применение | |
BRPI0519312A2 (pt) | composiÇço biologicamente ativa, composiÇço de liofilizaÇço, mÉtodo para a liofilizaÇço de virossomas utilizando as composiÇÕes, liofilizado de virossoma, mÉtodo para reconstituiÇço de um liofilizado de virossoma, uso de qualquer uma das composiÇÕes, kit, e, uso de um derivado de colesterila catiânico | |
PA8660601A1 (es) | Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso | |
PE20140621A1 (es) | Mejoras en o relacionadas con composiciones cementicias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |